A conceivable algorithm would be to first target oxidative cells within the tumour (e.g. by inhibition of PGC‐1α or of oxidative metabolism) and then, in a second step, to exploit specific vulnerabilities of remaining, for example, hypoxic cells. Here, PPARGC1A is linked to neoplasm.